Company Filing History:
Years Active: 2001-2025
Title: Dawn Gayle Flakne: Innovator in Neurostimulation Technology
Introduction
Dawn Gayle Flakne is a prominent inventor based in Portland, OR (US). She has made significant contributions to the field of neurostimulation technology, holding a total of 5 patents. Her work focuses on enhancing the functionality and accessibility of medical devices through innovative programming methods.
Latest Patents
One of her latest patents is titled "Remote follow-up of neurostimulation system." This invention outlines a method for remote programming a therapy device for neurostimulation. The process involves generating a stimulation program using a clinician programmer, transferring it to a patient programmer, and loading it onto the therapy device. Additionally, the patient programmer can increase the stimulation amplitude, starting from a minimal dose amplitude. Another notable patent is "System and method for data interrogation and/or remote programming of a medical device." This system includes a medical device, a remote monitoring server, and a patient remote device. The patient remote device is designed to establish bidirectional communication with both the remote monitoring server and the medical device, allowing for remote interrogation and programming.
Career Highlights
Dawn has worked with several notable companies in the medical technology sector, including Biotronik SE & Co. KG and Biotronik CRM Patent AG. Her experience in these organizations has allowed her to develop and refine her innovative ideas in neurostimulation.
Collaborations
Throughout her career, Dawn has collaborated with talented individuals such as Yarisa Jaroch Gonzalez and Alan Fryer. These partnerships have contributed to her success and the advancement of her inventions.
Conclusion
Dawn Gayle Flakne is a trailblazer in the field of neurostimulation technology, with a strong portfolio of patents that reflect her innovative spirit. Her contributions continue to impact the medical device industry positively.